- Title
- Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis
- Creators
- Binu V. John - University of MiamiDustin Bastaich - Virginia Commonwealth UniversityGwilym Webb - Cambridge University Hospitals NHS Foundation TrustTeresa Brevini - Wellcome/MRC Cambridge Stem Cell InstituteAndrew Moon - University of North Carolina at Chapel HillRaphaella D. Ferreira - Miami VA Healthcare SystemAllison M. Chin - Florida International UniversityDavid E. Kaplan - Philadelphia VA Medical CenterTamar H. Taddei - Yale UniversityMarina Serper - University of PennsylvaniaNadim Mahmud - University of PennsylvaniaYangyang Deng - Virginia Commonwealth UniversityHann Hsiang Chao - Department of Radiation Oncology, Central Virginia Health System, Richmond, VA, United StatesFotios Sampaziotis - Cambridge University Hospitals NHS Foundation TrustBassam Dahman - Virginia Commonwealth University
- Publication Details
- Journal of internal medicine, Vol.293(5), pp.636-647
- Number of pages
- 12
- Grant note
- P30 CA016059 / NIH‐NCI Cancer Center NIH-NCI
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hepatology
- Language
- English
- Resource Type
- Journal article
- PMID
- 37018129
- Record Identifier
- 991032796017402976
Journal article
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis
Journal of internal medicine, Vol.293(5), pp.636-647
2023-05
PMID: 37018129
Metrics
1 Record Views